masters in assisted reproductive technology
masters in assisted reproductive technology
The first-ever American Medical Society (AMS) conference on September 24th and 25th will deliver a full week of medical and scientific presentations on topics ranging from artificial intelligence, digital twins and robotic surgery to fertility services and the future of cancer research for new developments in reproductive medicine that have the potential to make an impact on people's lives.
The ISSA’s annual AID Conference has held the traditional format since 2012 with over 1,500 registrants in 50 countries from all over the world. Now in its seventh year, it is the largest medical exchange in the Americas, reaching more than 120,000 attendees representing clinicians, scientists, innovators, students and families seeking information about their respective careers in IVF, genetic testing, family planning, surrogacy and other reproductive modalities. More than 30% are women and 15% are minorities, including South Asians, Latinas and Asian Americans. Dr. John V. Holland III, president of AMS/ISSA says "The Master of Science degrees program is also unique – in fact, this is the only education program that features the majority of electives in two different areas of study at once!" He continues, "The Masters in Assisted Reproductive Technology provides students like me with opportunities to learn in one place while they build the foundations needed for many of the advanced educational pathways that are available in the field. It allows us to offer students exactly what is needed to advance themselves through advanced education in health care." This year, five master's degree programs in assisted reproductive technologies will be offered in 2022: urodynamics; embryology & fetal development; genomics; endocrinology and metabolism; ophthalmology and optometry. To request the information or register for your conference visit https://aids.assistivecare.org/.
In addition to theses and concentrations, there is a lot to fit into this busy schedule for participants, faculty and presenters. For example, it includes 11 conferences across four days, a plenary session, several poster sessions, as well as workshops, lectures and networking events. All this competition can be overwhelming, but we hope our strong support of graduate students will help each attendee feel confident enough and comfortable enough in attending. Because the Masters in Assisted Reproductive Technology requires you to do so much before graduation on these long months, students who complete this program will be among the most prepared to participate fully in postgraduate medical training. There are multiple ways people get involved in medicine, whether it's through volunteering with a non-profit organization or becoming board members of a professional association. Our academic network here in the United States is incredibly active. We have alumni who serve on national committees and boards, and those who share the experience with our colleagues. Students who complete this program will have everything to succeed in a career in medicine and hopefully find additional avenues for leadership or advancement as they pursue higher levels of education while working toward their PhD, MS or MD degrees. This isn't an easy endeavor for anyone, but we want you to know that we take the time to make sure every step along the way makes for a rewarding and fulfilling life here in medicine."
Each year thousands of patients seek out clinical trials, hoping to obtain access to treatments that promise them better health outcomes or better disease management. But how many can successfully find trials that are appropriate? How many would ultimately realize their goal of getting an effective treatment? For some, obtaining access to trials is still not possible. They may need to travel further away from home or even abroad to find trials that meet their specific needs, often without support from government agencies or nonprofit organizations. To address this challenge, researchers have created 'assisted reproductive technologies' (ARTs) and they continue to look for clinical trial options for individuals and families who want to have children or treat illnesses and conditions that are difficult to treat. ARTs include artificial insemination (AII), embryo transfer and egg freezing, in vitro fertilization (IVF), genetic testing for disorders, infertility issues, pregnancy loss, and gender selection. To assist these individuals and families, ISSA established the Clinical Trials Assistance Program (CTAP) in 2006.
The first-ever American Medical Society (AMS) conference on September 24th and 25th will deliver a full week of medical and scientific presentations on topics ranging from artificial intelligence, digital twins and robotic surgery to fertility services and the future of cancer research for new developments in reproductive medicine that have the potential to make an impact on people's lives.
The ISSA’s annual AID Conference has held the traditional format since 2012 with over 1,500 registrants in 50 countries from all over the world. Now in its seventh year, it is the largest medical exchange in the Americas, reaching more than 120,000 attendees representing clinicians, scientists, innovators, students and families seeking information about their respective careers in IVF, genetic testing, family planning, surrogacy and other reproductive modalities. More than 30% are women and 15% are minorities, including South Asians, Latinas and Asian Americans. Dr. John V. Holland III, president of AMS/ISSA says "The Master of Science degrees program is also unique – in fact, this is the only education program that features the majority of electives in two different areas of study at once!" He continues, "The Masters in Assisted Reproductive Technology provides students like me with opportunities to learn in one place while they build the foundations needed for many of the advanced educational pathways that are available in the field. It allows us to offer students exactly what is needed to advance themselves through advanced education in health care." This year, five master's degree programs in assisted reproductive technologies will be offered in 2022: urodynamics; embryology & fetal development; genomics; endocrinology and metabolism; ophthalmology and optometry. To request the information or register for your conference visit https://aids.assistivecare.org/.
In addition to theses and concentrations, there is a lot to fit into this busy schedule for participants, faculty and presenters. For example, it includes 11 conferences across four days, a plenary session, several poster sessions, as well as workshops, lectures and networking events. All this competition can be overwhelming, but we hope our strong support of graduate students will help each attendee feel confident enough and comfortable enough in attending. Because the Masters in Assisted Reproductive Technology requires you to do so much before graduation on these long months, students who complete this program will be among the most prepared to participate fully in postgraduate medical training. There are multiple ways people get involved in medicine, whether it's through volunteering with a non-profit organization or becoming board members of a professional association. Our academic network here in the United States is incredibly active. We have alumni who serve on national committees and boards, and those who share the experience with our colleagues. Students who complete this program will have everything to succeed in a career in medicine and hopefully find additional avenues for leadership or advancement as they pursue higher levels of education while working toward their PhD, MS or MD degrees. This isn't an easy endeavor for anyone, but we want you to know that we take the time to make sure every step along the way makes for a rewarding and fulfilling life here in medicine."
Each year thousands of patients seek out clinical trials, hoping to obtain access to treatments that promise them better health outcomes or better disease management. But how many can successfully find trials that are appropriate? How many would ultimately realize their goal of getting an effective treatment? For some, obtaining access to trials is still not possible. They may need to travel further away from home or even abroad to find trials that meet their specific needs, often without support from government agencies or nonprofit organizations. To address this challenge, researchers have created 'assisted reproductive technologies' (ARTs) and they continue to look for clinical trial options for individuals and families who want to have children or treat illnesses and conditions that are difficult to treat. ARTs include artificial insemination (AII), embryo transfer and egg freezing, in vitro fertilization (IVF), genetic testing for disorders, infertility issues, pregnancy loss, and gender selection. To assist these individuals and families, ISSA established the Clinical Trials Assistance Program (CTAP) in 2006.
